LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,135
تعداد مقالات10,361
تعداد مشاهده مقاله44,010,214
تعداد دریافت فایل اصل مقاله9,942,016
Shirani, Kiana, Sheikhbahaei, Erfan, Torkpour, Zahra, Ghadiri Nejad, Mazyar, Kamyab Moghadas, Bahareh, Ghasemi, Matina, Akbari Aghdam, Hossein, Ehsani, Athena, Saber-Samandari, Saeed, Khandan, Amirsalar. (1399). A Narrative Review of COVID-19: The New Pandemic Disease. سامانه مدیریت نشریات علمی, 45(4), 233-249. doi: 10.30476/ijms.2020.85869.1549
Kiana Shirani; Erfan Sheikhbahaei; Zahra Torkpour; Mazyar Ghadiri Nejad; Bahareh Kamyab Moghadas; Matina Ghasemi; Hossein Akbari Aghdam; Athena Ehsani; Saeed Saber-Samandari; Amirsalar Khandan. "A Narrative Review of COVID-19: The New Pandemic Disease". سامانه مدیریت نشریات علمی, 45, 4, 1399, 233-249. doi: 10.30476/ijms.2020.85869.1549
Shirani, Kiana, Sheikhbahaei, Erfan, Torkpour, Zahra, Ghadiri Nejad, Mazyar, Kamyab Moghadas, Bahareh, Ghasemi, Matina, Akbari Aghdam, Hossein, Ehsani, Athena, Saber-Samandari, Saeed, Khandan, Amirsalar. (1399). 'A Narrative Review of COVID-19: The New Pandemic Disease', سامانه مدیریت نشریات علمی, 45(4), pp. 233-249. doi: 10.30476/ijms.2020.85869.1549
Shirani, Kiana, Sheikhbahaei, Erfan, Torkpour, Zahra, Ghadiri Nejad, Mazyar, Kamyab Moghadas, Bahareh, Ghasemi, Matina, Akbari Aghdam, Hossein, Ehsani, Athena, Saber-Samandari, Saeed, Khandan, Amirsalar. A Narrative Review of COVID-19: The New Pandemic Disease. سامانه مدیریت نشریات علمی, 1399; 45(4): 233-249. doi: 10.30476/ijms.2020.85869.1549

A Narrative Review of COVID-19: The New Pandemic Disease

Iranian Journal of Medical Sciences
مقاله 2، دوره 45، شماره 4، مهر 2020، صفحه 233-249    اصل مقاله (1.35 M)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.30476/ijms.2020.85869.1549
نویسندگان
Kiana Shirani1؛ Erfan Sheikhbahaei2؛ Zahra Torkpour2؛ Mazyar Ghadiri Nejad3؛ Bahareh Kamyab Moghadas4؛ Matina Ghasemi5؛ Hossein Akbari Aghdam6؛ Athena Ehsani7؛ Saeed Saber-Samandari8؛ Amirsalar Khandan* 9، 10
1Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3Industrial Engineering Department, Girne American University, Kyrenia, TRNC, Turkey
4Department of Chemical Engineering, Shiraz Branch, Islamic Azad University, Shiraz, Iran
5Faculty of Business and Economics, Business Department, Girne American University, Kyrenia, TRNC, Turkey
6Department of Orthopedic Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
7Department of Biomedical Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran
8New Technologies Research Center, Amirkabir University of Technology, Tehran, Iran
9Department of Electrical Engineering, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran
10Technology Incubator Center, Isfahan (Khorasgan) Branch, Islamic Azad University, Isfahan, Iran
چکیده
Nearly every 100 years, humans collectively face a pandemic crisis. After the Spanish flu, now the world is in the grip of coronavirus disease 2019 (COVID-19). First detected in 2019 in the Chinese city of Wuhan, COVID-19 causes severe acute respiratory distress syndrome. Despite the initial evidence indicating a zoonotic origin, the contagion is now known to primarily spread from person to person through respiratory droplets. The precautionary measures recommended by the scientific community to halt the fast transmission of the disease failed to prevent this contagious disease from becoming a pandemic for a whole host of reasons. After an incubation period of about two days to two weeks, a spectrum of clinical manifestations can be seen in individuals afflicted by COVID-19: from an asymptomatic condition that can spread the virus in the environment, to a mild/moderate disease with cold/flu-like symptoms, to deteriorated conditions that need hospitalization and intensive care unit management, and then a fatal respiratory distress syndrome that becomes refractory to oxygenation. Several diagnostic modalities have been advocated and evaluated; however, in some cases, diagnosis is made on the clinical picture in order not to lose time. A consensus on what constitutes special treatment for COVID-19 has yet to emerge. Alongside conservative and supportive care, some potential drugs have been recommended and a considerable number of investigations are ongoing in this regard.
کلیدواژه‌ها
SARS virus؛ COVID-19؛ Epidemiology؛ Pandemics؛ Coronavirus
سایر فایل های مرتبط با مقاله
مراجع
  1. Corman VM, Muth D, Niemeyer D, Drosten C. Hosts and Sources of Endemic Human Coronaviruses. Adv Virus Res. 2018;100:163-88. doi: 10.1016/bs.aivir.2018.01.001. PubMed PMID: 29551135; PubMed Central PMCID: PMCPMC7112090.
  2. Smith RD. Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management. Soc Sci Med. 2006;63:3113-23. doi: 10.1016/j.socscimed.2006.08.004. PubMed PMID: 16978751; PubMed Central PMCID: PMCPMC7130909.
  3. Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl). 2020;133:1015-24. doi: 10.1097/CM9.0000000000000722. PubMed PMID: 32004165; PubMed Central PMCID: PMCPMC7147275.
  4. Memish ZA, Al-Tawfiq JA, Assiri A, AlRabiah FA, Al Hajjar S, Albarrak A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J. 2014;33:904-6. doi: 10.1097/INF.0000000000000325. PubMed PMID: 24763193.
  5. Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia. World J Clin Pediatr. 2016;5:391-6. doi: 10.5409/wjcp.v5.i4.391. PubMed PMID: 27872828; PubMed Central PMCID: PMCPMC5099592.
  6. Nishiura H, Jung SM, Linton NM, Kinoshita R, Yang Y, Hayashi K, et al. The Extent of Transmission of Novel Coronavirus in Wuhan, China, 2020. J Clin Med. 2020;9. doi: 10.3390/jcm9020330. PubMed PMID: 31991628; PubMed Central PMCID: PMCPMC7073674.
  7. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. doi: 10.1016/S0140-6736(20)30183-5. PubMed PMID: 31986264; PubMed Central PMCID: PMCPMC7159299.
  8. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3. doi: 10.1038/s41586-020-2012-7. PubMed PMID: 32015507; PubMed Central PMCID: PMCPMC7095418.
  9. Sarkar B, Ullah MA, Johora FT, Taniya MA, Araf Y. The Essential Facts of Wuhan Novel Coronavirus Outbreak in China and Epitope-based Vaccine Designing against 2019-nCoV. BioRxiv. 2020. doi: 10.1101/2020.02.05.935072.
  10. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020;133:1025-31. doi: 10.1097/CM9.0000000000000744. PubMed PMID: 32044814; PubMed Central PMCID: PMCPMC7147277.
  11. Control CfD, Prevention. Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection. Updated February 12, 2020. 2020.
  12. Organization WH. Novel Coronavirus (2019-nCoV) technical guidance: Patient management. 2020.
  13. Organization WH. Home care for patients with suspected novel coronavirus (nCoV) infection presenting with mild symptoms and management of contacts. 2020.
  14. Otter JA, Donskey C, Yezli S, Douthwaite S, Goldenberg SD, Weber DJ. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J Hosp Infect. 2016;92:235-50. doi: 10.1016/j.jhin.2015.08.027. PubMed PMID: 26597631; PubMed Central PMCID: PMCPMC7114921.
  15. McIntosh K. Novel coronavirus (2019-nCoV). 2020.
  16. Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med. 2017;9. doi: 10.1126/scitranslmed.aal3653. PubMed PMID: 28659436; PubMed Central PMCID: PMCPMC5567817.
  17. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30:269-71. doi: 10.1038/s41422-020-0282-0. PubMed PMID: 32020029; PubMed Central PMCID: PMCPMC7054408.
  18. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382:929-36. doi: 10.1056/NEJMoa2001191. PubMed PMID: 32004427; PubMed Central PMCID: PMCPMC7092802.
  19. Groneberg DA, Poutanen SM, Low DE, Lode H, Welte T, Zabel P. Treatment and vaccines for severe acute respiratory syndrome. Lancet Infect Dis. 2005;5:147-55. doi: 10.1016/S1473-3099(05)01307-1. PubMed PMID: 15766649; PubMed Central PMCID: PMCPMC7106466.
  20. Chan JF, Yao Y, Yeung ML, Deng W, Bao L, Jia L, et al. Treatment With Lopinavir/Ritonavir or Interferon-beta1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015;212:1904-13. doi: 10.1093/infdis/jiv392. PubMed PMID: 26198719; PubMed Central PMCID: PMCPMC7107395.
  21. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. The Author’s Response: Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci. 2020;35:e89. doi: 10.3346/jkms.2020.35.e89. PubMed PMID: 32080993.
  22. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 2020;14:64-8. doi: 10.5582/bst.2020.01030. PubMed PMID: 32037389.
  23. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA. 2020. doi: 10.1001/jama.2020.3204. PubMed PMID: 32125362; PubMed Central PMCID: PMCPMC7054855.
  24. Colson P, Rolain JM, Raoult D. Chloroquine for the 2019 novel coronavirus SARS-CoV-2. Int J Antimicrob Agents. 2020;55:105923. doi: 10.1016/j.ijantimicag.2020.105923. PubMed PMID: 32070753; PubMed Central PMCID: PMCPMC7134866.
  25. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020. doi: 10.1093/cid/ciaa237. PubMed PMID: 32150618; PubMed Central PMCID: PMCPMC7108130.
  26. McIntosh K, Hirsch MS, Bloom A. Coronavirus disease 2019 (COVID-19). UpToDate Hirsch MS Bloom. 2020;5.
  27. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020;222:415-26. doi: 10.1016/j.ajog.2020.02.017. PubMed PMID: 32105680; PubMed Central PMCID: PMCPMC7093856.
  28. Tabari P, Amini M, Moghadami M, Moosavi M. International Public Health Responses to COVID-19 Outbreak: A Rapid Review. Iran J Med Sci. 2020;45:157-69. doi: 10.30476/ijms.2020.85810.1537. PubMed PMID: 32546882; PubMed Central PMCID: PMCPMC7253494.
  29. Negahdaripour M. The Battle Against COVID-19: Where Do We Stand Now? Iran J Med Sci. 2020;45:81-2. doi: 10.30476/ijms.2020.46357. PubMed PMID: 32210483; PubMed Central PMCID: PMCPMC7071545.
  30. Bahadori M, Yaghoubi M, Haghgoshyie E, Ghasemi M, Hasanpoor E. Patients’ and physicians’ perspectives and experiences on the quality of medical consultations: a qualitative study. Int J Evid Based Healthc. 2020;18:247-55. doi: 10.1097/XEB.0000000000000210. PubMed PMID: 31714340.
  31. Ghasemi M, Ghadiri Nejad M, Bagzibagli K. Knowledge Management Orientation: An Innovative Perspective to Hospital Management. Iran J Public Health. 2017;46:1639-45. PubMed PMID: 29259938; PubMed Central PMCID: PMCPMC5734963.
  32. Ghadirinejad M, Atasoylu E, Izbirak G, Gha-Semi M. A Stochastic Model for the Ethanol Pharmacokinetics. Iran J Public Health. 2016;45:1170-8. PubMed PMID: 27957462; PubMed Central PMCID: PMCPMC5149471.
  33. Raj VS, Osterhaus AD, Fouchier RA, Haagmans BL. MERS: emergence of a novel human coronavirus. Curr Opin Virol. 2014;5:58-62. doi: 10.1016/j.coviro.2014.01.010. PubMed PMID: 24584035; PubMed Central PMCID: PMCPMC4028407.
  34. Banik GR, Khandaker G, Rashid H. Middle East respiratory syndrome coronavirus “MERS-CoV”: current knowledge gaps. Paediatr Respir Rev. 2015;16:197-202. doi: 10.1016/j.prrv.2015.04.002. PubMed PMID: 26002405; PubMed Central PMCID: PMCPMC7106011.
  35. Hemida MG, Perera RA, Wang P, Alhammadi MA, Siu LY, Li M, et al. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013;18:20659. doi: 10.2807/1560-7917.es2013.18.50.20659. PubMed PMID: 24342517.
  36. Ismail MM, Cho KO, Ward LA, Saif LJ, Saif YM. Experimental bovine coronavirus in turkey poults and young chickens. Avian Dis. 2001;45:157-63. PubMed PMID: 11332477.
  37. Moon HW, Bemrick WJ. Fecal transmission of calf cryptosporidia between calves and pigs. Vet Pathol. 1981;18:248-55. doi: 10.1177/030098588101800213. PubMed PMID: 7467084.
  38. Bhatt PN, Percy DH, Jonas AM. Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group. J Infect Dis. 1972;126:123-30. doi: 10.1093/infdis/126.2.123. PubMed PMID: 4559849; PubMed Central PMCID: PMCPMC7110018.
  39. Mackay IM, Arden KE. MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015;12:222. doi: 10.1186/s12985-015-0439-5. PubMed PMID: 26695637; PubMed Central PMCID: PMCPMC4687373.
  40. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis. 2013;19:1819-23. doi: 10.3201/eid1911.131172. PubMed PMID: 24206838; PubMed Central PMCID: PMCPMC3837665.
  41. Cotten M, Watson SJ, Kellam P, Al-Rabeeah AA, Makhdoom HQ, Assiri A, et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet. 2013;382:1993-2002. doi: 10.1016/S0140-6736(13)61887-5. PubMed PMID: 24055451; PubMed Central PMCID: PMCPMC3898949
  42. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science. 2003;302:276-8. doi: 10.1126/science.1087139. PubMed PMID: 12958366.
  43. Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, et al. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.3.2000044. PubMed PMID: 31992388; PubMed Central PMCID: PMCPMC6988272.
  44. Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020. doi: 10.1038/s41586-020-2169-0. PubMed PMID: 32218527.
  45. Cheng ZJ, Shan J. 2019 Novel coronavirus: where we are and what we know. Infection. 2020;48:155-63. doi: 10.1007/s15010-020-01401-y. PubMed PMID: 32072569; PubMed Central PMCID: PMCPMC7095345.
  46. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382:970-1. doi: 10.1056/NEJMc2001468. PubMed PMID: 32003551; PubMed Central PMCID: PMCPMC7120970.
  47. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020;92:491-4. doi: 10.1002/jmv.25709. PubMed PMID: 32056249; PubMed Central PMCID: PMCPMC7166760.
  48. Weiss SR, Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005;69:635-64. doi: 10.1128/MMBR.69.4.635-664.2005. PubMed PMID: 16339739; PubMed Central PMCID: PMCPMC1306801.
  49. Pickett BE, Greer DS, Zhang Y, Stewart L, Zhou L, Sun G, et al. Virus pathogen database and analysis resource (ViPR): a comprehensive bioinformatics database and analysis resource for the coronavirus research community. Viruses. 2012;4:3209-26. doi: 10.3390/v4113209. PubMed PMID: 23202522; PubMed Central PMCID: PMCPMC3509690.
  50. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533-5. doi: 10.1038/s41423-020-0402-2. PubMed PMID: 32203188; PubMed Central PMCID: PMCPMC7091858.
  51. Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L, et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19). Front Immunol. 2020;11:827. doi: 10.3389/fimmu.2020.00827. PubMed PMID: 32425950; PubMed Central PMCID: PMCPMC7205903.
  52. Liu W, Li H. COVID-19: attacks the 1-beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism. Preprint revised on. 2020;10. doi: 10.26434/chemrxiv.11938173.v4.
  53. Li S, Yue J, Dong BR, Yang M, Lin X, Wu T. Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database Syst Rev. 2013:CD008800. doi: 10.1002/14651858.CD008800.pub2. PubMed PMID: 23818046.
  54. Winther B. Pathogenesis of viral induced rhinitis. The Nose. 1998;8:135.
  55. Haynes L, Szaba FM, Eaton SM, Kummer LW, Lanthier PA, Petell AH, et al. Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections. J Immunol. 2012;189:4921-9. doi: 10.4049/jimmunol.1201916. PubMed PMID: 23028058; PubMed Central PMCID: PMCPMC3490014.
  56. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. doi: 10.1016/S0140-6736(20)30211-7. PubMed PMID: 32007143; PubMed Central PMCID: PMCPMC7135076.
  57. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020. doi: 10.1001/jama.2020.1585. PubMed PMID: 32031570; PubMed Central PMCID: PMCPMC7042881.
  58. Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425-34. doi: 10.1016/S1473-3099(20)30086-4. PubMed PMID: 32105637; PubMed Central PMCID: PMCPMC7159053.
  59. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol. 2020;214:1072-7. doi: 10.2214/AJR.20.22976. PubMed PMID: 32125873.
  60. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020:200642. doi: 10.1148/radiol.2020200642. PubMed PMID: 32101510; PubMed Central PMCID: PMCPMC7233399.
  61. Bai HX, Hsieh B, Xiong Z, Halsey K, Choi JW, Tran TML, et al. Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT. Radiology. 2020:200823. doi: 10.1148/radiol.2020200823. PubMed PMID: 32155105; PubMed Central PMCID: PMCPMC7233414.
  62. Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020. doi: 10.1001/jama.2020.2565. PubMed PMID: 32083643; PubMed Central PMCID: PMCPMC7042844.
  63. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing. Radiology. 2020:200343. doi: 10.1148/radiol.2020200343. PubMed PMID: 32049601; PubMed Central PMCID: PMCPMC7233363.
  64. Patel A, Jernigan DB, nCo VCDCRT. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:140-6. doi: 10.15585/mmwr.mm6905e1. PubMed PMID: 32027631; PubMed Central PMCID: PMCPMC7004396.
  65. Organization WH. Coronavirus disease (COVID-19) technical guidance: Surveillance and case definitions. Geneva: World Health Organization; 2020.
  66. Organization WH. Updated WHO advice for international traffic in relation to the outbreak of the novel coronavirus 2019-nCoV, 24 January 2020. Geneva: World Health Organization; 2020.
  67. Cho KO, Hasoksuz M, Nielsen PR, Chang KO, Lathrop S, Saif LJ. Cross-protection studies between respiratory and calf diarrhea and winter dysentery coronavirus strains in calves and RT-PCR and nested PCR for their detection. Arch Virol. 2001;146:2401-19. doi: 10.1007/s007050170011. PubMed PMID: 11811688; PubMed Central PMCID: PMCPMC7087283.
  68. Chow KC, Hsiao CH, Lin TY, Chen CL, Chiou SH. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am J Clin Pathol. 2004;121:574-80. doi: 10.1309/C0ED-U0RA-QBTX-BHCE. PubMed PMID: 15080310; PubMed Central PMCID: PMCPMC7109992.
  69. Saul AW. Nutritional treatment of coronavirus. Orthomolecular Medicine News Service. 2020;16:22.
  70. Lu CC, Chen MY, Lee WS, Chang YL. Potential therapeutic agents against COVID-19: What we know so far. J Chin Med Assoc. 2020;83:534-6. doi: 10.1097/JCMA.0000000000000318. PubMed PMID: 32243270; PubMed Central PMCID: PMCPMC7176266.
  71. Qin X, Qiu S, Yuan Y, Zong Y, Tuo Z, Li J, et al. Clinical characteristics and treatment of patients infected with COVID-19 in Shishou, China. China (February 18, 2020). 2020. doi: 10.2139/ssrn.3541147.
  72. Pourdowlat G, Panahi P, Pooransari P, Ghorbani F. Prophylactic Recommendation for Healthcare Workers in COVID-19 Pandemic. Advanced Journal of Emergency Medicine. 2020;4:e39.
  73. Anastassopoulou C, Russo L, Tsakris A, Siettos C. Data-based analysis, modelling and forecasting of the COVID-19 outbreak. PLoS One. 2020;15:e0230405. doi: 10.1371/journal.pone.0230405. PubMed PMID: 32231374; PubMed Central PMCID: PMCPMC7108749.
  74. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020;295:715-21. doi: 10.1148/radiol.2020200370. PubMed PMID: 32053470; PubMed Central PMCID: PMCPMC7233367.
  75. Winter G. COVID-19 and emergency planning. Br J Community Nurs. 2020;25:184-6. doi: 10.12968/bjcn.2020.25.4.184. PubMed PMID: 32267768.
  76. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. JAMA. 2020. doi: 10.1001/jama.2020.2783. PubMed PMID: 32105304; PubMed Central PMCID: PMCPMC7047852.
  77. Fintelman-Rodrigues N, Sacramento CQ, Lima CR, da Silva FS, Ferreira A, Mattos M, et al. Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production. bioRxiv. 2020.
  78. Ford N, Vitoria M, Rangaraj A, Norris SL, Calmy A, Doherty M. Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: initial assessment. J Int AIDS Soc. 2020;23:e25489. doi: 10.1002/jia2.25489. PubMed PMID: 32293807; PubMed Central PMCID: PMCPMC7158851.
  79. Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, et al. Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study. Engineering (Beijing). 2020. doi: 10.1016/j.eng.2020.03.007. PubMed PMID: 32346491; PubMed Central PMCID: PMCPMC7185795.
  80. Chen C, Huang J, Cheng Z, Wu J, Chen S, Zhang Y, et al. Favipiravir versus arbidol for COVID-19: a randomized clinical trial. MedRxiv. 2020. doi: 10.1101/2020.03.17.20037432.
  81. Shi P, Cao S, Feng P. SEIR Transmission dynamics model of 2019 nCoV coronavirus with considering the weak infectious ability and changes in latency duration. MedRxiv. 2020. doi: 10.1101/2020.02.16.20023655.
  82. Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477. doi: 10.1016/j.lfs.2020.117477. PubMed PMID: 32119961; PubMed Central PMCID: PMCPMC7089605.
  83. Khalili JS, Zhu H, Mak NSA, Yan Y, Zhu Y. Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19. J Med Virol. 2020;92:740-6. doi: 10.1002/jmv.25798. PubMed PMID: 32227493; PubMed Central PMCID: PMCPMC7228408.
  84. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther. 2020;14:58-60. doi: 10.5582/ddt.2020.01012. PubMed PMID: 32147628.
  85. Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14:69-71. doi: 10.5582/bst.2020.01020. PubMed PMID: 31996494.
  86. Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N. Type 1 interferons as a potential treatment against COVID-19. Antiviral Res. 2020;178:104791. doi: 10.1016/j.antiviral.2020.104791. PubMed PMID: 32275914; PubMed Central PMCID: PMCPMC7138382.
  87. Anderson PO. Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza. Breastfeed Med. 2020;15:128. doi: 10.1089/bfm.2020.29149.poa. PubMed PMID: 32129667.
  88. Saif LJ. Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? Rev Sci Tech. 2004;23:643-60. doi: 10.20506/rst.23.2.1513. PubMed PMID: 15702725.
  89. Tsunemitsu H, Smith DR, Saif LJ. Experimental inoculation of adult dairy cows with bovine coronavirus and detection of coronavirus in feces by RT-PCR. Arch Virol. 1999;144:167-75. doi: 10.1007/s007050050493. PubMed PMID: 10076517; PubMed Central PMCID: PMCPMC7086631.
  90. Giomarelli P, Scolletta S, Borrelli E, Biagioli B. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg. 2003;76:117-23. doi: 10.1016/s0003-4975(03)00194-2. PubMed PMID: 12842524.
  91. Vanr K, Nauwynck H, Pensaert M. A potential role for tumour necrosis factor-alpha in synergy between porcine respiratory coronavirus and bacterial lipopolysaccharide in the induction of respiratory disease in pigs. J Med Microbiol. 2000;49:613-20. doi: 10.1099/0022-1317-49-7-613. PubMed PMID: 10882086.
  92. Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol. 2020;38:379-81. doi: 10.1038/d41587-020-00003-1. PubMed PMID: 32205870.
  93. Cavanagh D, Naqi S. Infectious bronchitis. Diseases of poultry. 2003;11:101-19.
  94. Centers for Disease C, Prevention. Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:986-7. PubMed PMID: 14561956.
  95. Chim SS, Tsui SK, Chan KC, Au TC, Hung EC, Tong YK, et al. Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet. 2003;362:1807-8. doi: 10.1016/s0140-6736(03)14901-x. PubMed PMID: 14654320; PubMed Central PMCID: PMCPMC7119348.
  96. Cho KO, Hoet AE, Loerch SC, Wittum TE, Saif LJ. Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle. Am J Vet Res. 2001;62:1436-41. doi: 10.2460/ajvr.2001.62.1436. PubMed PMID: 11560274.
  97. Mehra MR, Desai SS, Ruschitzka F, Patel AN. RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020. doi: 10.1016/S0140-6736(20)31180-6. PubMed PMID: 32450107; PubMed Central PMCID: PMCPMC7255293.
  98. Peduto Hand F, Choudhury RA, Gubler WD. First Report of Cytospora punicae Causing Wood Canker and Branch Dieback of Pomegranate (Punica granatum) in the United States. Plant Dis. 2014;98:853. doi: 10.1094/PDIS-11-13-1133-PDN. PubMed PMID: 30708682.
  99. Saul AW. Vitamin C Protects Against Coronavirus. 2020.
  100. Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Crit Care. 2020;24:133. doi: 10.1186/s13054-020-02851-4. PubMed PMID: 32264963; PubMed Central PMCID: PMCPMC7137406.
  101. Cheng RZ. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Med Drug Discov. 2020;5:100028. doi: 10.1016/j.medidd.2020.100028. PubMed PMID: 32328576; PubMed Central PMCID: PMCPMC7167497.
  102. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12. doi: 10.3390/nu12040988. PubMed PMID: 32252338; PubMed Central PMCID: PMCPMC7231123.
  103. Robb JA, Bond CW. Pathogenic murine coronaviruses. I. Characterization of biological behavior in vitro and virus-specific intracellular RNA of strongly neurotropic JHMV and weakly neurotropic A59V viruses. Virology. 1979;94:352-70. doi: 10.1016/0042-6822(79)90467-7. PubMed PMID: 572112; PubMed Central PMCID: PMCPMC7131751.
  104. Feldmann HR, Williams DR, Champagne JD, Lehenbauer TW, Aly SS. Effectiveness of zinc supplementation on diarrhea and average daily gain in pre-weaned dairy calves: A double-blind, block-randomized, placebo-controlled clinical trial. PLoS One. 2019;14:e0219321. doi: 10.1371/journal.pone.0219321. PubMed PMID: 31291305; PubMed Central PMCID: PMCPMC6619766.
  105. Senathilake K, Samarakoon S, Tennekoon K. Virtual screening of inhibitors against spike glycoprotein of 2019 novel corona virus: A drug repurposing approach. 2020.
  106. John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH, Butterfield LH, et al. Zinc in innate and adaptive tumor immunity. J Transl Med. 2010;8:118. doi: 10.1186/1479-5876-8-118. PubMed PMID: 21087493; PubMed Central PMCID: PMCPMC3002329.
  107. Chasapis CT, Loutsidou AC, Spiliopoulou CA, Stefanidou ME. Zinc and human health: an update. Arch Toxicol. 2012;86:521-34. doi: 10.1007/s00204-011-0775-1. PubMed PMID: 22071549.
  108. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420-2. doi: 10.1016/S2213-2600(20)30076-X. PubMed PMID: 32085846; PubMed Central PMCID: PMCPMC7164771.
  109. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. PubMed PMID: 31992387; PubMed Central PMCID: PMCPMC6988269.
  110. Chu DKW, Pan Y, Cheng SMS, Hui KPY, Krishnan P, Liu Y, et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia. Clin Chem. 2020;66:549-55. doi: 10.1093/clinchem/hvaa029. PubMed PMID: 32031583; PubMed Central PMCID: PMCPMC7108203.
  111. Pang J, Wang MX, Ang IYH, Tan SHX, Lewis RF, Chen JI, et al. Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review. J Clin Med. 2020;9. doi: 10.3390/jcm9030623. PubMed PMID: 32110875; PubMed Central PMCID: PMCPMC7141113.
  112. Lau LT, Fung YW, Wong FP, Lin SS, Wang CR, Li HL, et al. A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification. Biochem Biophys Res Commun. 2003;312:1290-6. doi: 10.1016/j.bbrc.2003.11.064. PubMed PMID: 14652014; PubMed Central PMCID: PMCPMC7111096.
  113. Hui RK, Zeng F, Chan CM, Yuen KY, Peiris JS, Leung FC. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol. 2004;42:1994-9. doi: 10.1128/jcm.42.5.1994-1999.2004. PubMed PMID: 15131160; PubMed Central PMCID: PMCPMC404607.
  114. Poon LL, Chan KH, Wong OK, Yam WC, Yuen KY, Guan Y, et al. Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol. 2003;28:233-8. doi: 10.1016/j.jcv.2003.08.004. PubMed PMID: 14522060; PubMed Central PMCID: PMCPMC7129783.
  115. Jiang SS, Chen TC, Yang JY, Hsiung CA, Su IJ, Liu YL, et al. Sensitive and quantitative detection of severe acute respiratory syndrome coronavirus infection by real-time nested polymerase chain reaction. Clin Infect Dis. 2004;38:293-6. doi: 10.1086/380841. PubMed PMID: 14699465; PubMed Central PMCID: PMCPMC7107825.
  116. Beck B, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model. bioRxiv. 2020.
  117. Xu X, Jiang X, Ma C, Du P, Li X, Lv S, et al. Deep learning system to screen coronavirus disease 2019 pneumonia. arXiv 2020. arXiv preprint arXiv:200209334.
  118. Control CfD, Prevention. Interim Considerations for Disposition of Hospitalized Patients with 2019-nCoV Infection. 2020.
  119. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104:246-51. doi: 10.1016/j.jhin.2020.01.022. PubMed PMID: 32035997; PubMed Central PMCID: PMCPMC7132493.
  120. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020. doi: 10.1001/jama.2020.3227. PubMed PMID: 32129805; PubMed Central PMCID: PMCPMC7057172.
  121. Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1-6. doi: 10.1007/s00430-004-0219-0. PubMed PMID: 15118911; PubMed Central PMCID: PMCPMC7086689.
  122. Organization WH [Internet]. Advice on the use of masks the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. c2020 [Cited 5 Feb 2020]. Avilble from: https://apps.who.int/iris/bitstream/handle/10665/331493/WHO-2019-nCoV-IPC_Masks-2020.2-eng.pdf
  123. Organization WH. Key considerations for repatriation and quarantine of travellers in relation to the outbreak of novel coronavirus 2019-nCoV: 11 February 2020. 2020d.
  124. Hoehl S, Rabenau H, Berger A, Kortenbusch M, Cinatl J, Bojkova D, et al. Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China. N Engl J Med. 2020;382:1278-80. doi: 10.1056/NEJMc2001899. PubMed PMID: 32069388; PubMed Central PMCID: PMCPMC7121749.
آمار
تعداد مشاهده مقاله: 5,046
تعداد دریافت فایل اصل مقاله: 2,980


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب